Es gab 50 kürzliche Insider-Transaktionen für Pliant Therapeutics, Inc. (PLRX), darunter 32 Käufe und 16 Verkäufe. Die gesamten Insider-Käufe beliefen sich auf $14.05M und die gesamten Insider-Verkäufe auf $2.58M.
Bedeutende Insider mit kürzlicher Aktivität umfassen Coulie Bernard, Cummings Keith Lamont, Cheung Lily. Insider-Transaktionen können Einblicke geben, wie die Unternehmensführung die Bewertung und Zukunftsaussichten der Aktie einschätzt.
Insider-Transaktionen — PLRX
| Datum |
Name |
Funktion |
Transaktionsart |
Aktien |
Ø Preis |
Wert |
Gehaltene Aktien |
| 2026-01-22 |
Coulie Bernard |
President and CEO |
RSU-Zuteilung |
1,230,000 |
$1.30 |
$1.6M |
1,230,000 |
| 2026-01-22 |
Cummings Keith Lamont |
Chief Financial Officer |
RSU-Zuteilung |
400,000 |
$1.30 |
$520K |
400,000 |
| 2026-01-22 |
Cheung Lily |
Chief Human Resource Officer |
RSU-Zuteilung |
300,000 |
$1.30 |
$390K |
300,000 |
| 2026-01-22 |
Kuo Minnie |
Chief Operating Officer |
RSU-Zuteilung |
300,000 |
$1.30 |
$390K |
300,000 |
| 2026-01-20 |
Coulie Bernard |
President and CEO |
Informierter Verkauf |
89,375 |
$1.28 |
$114.4K |
505,601 |
| 2026-01-20 |
Cummings Keith Lamont |
Chief Financial Officer |
Informierter Verkauf |
24,002 |
$1.28 |
$30.72K |
297,214 |
| 2026-01-20 |
Cheung Lily |
Chief Human Resource Officer |
Informierter Verkauf |
7,534 |
$1.28 |
$9.64K |
44,847 |
| 2026-01-20 |
Kuo Minnie |
Chief Operating Officer |
Informierter Verkauf |
6,917 |
$1.28 |
$8.85K |
37,806 |
| 2025-12-10 |
Kuo Minnie |
Chief Operating Officer |
Unbekannt |
55,200 |
$11.14 |
$614.93K |
- |
| 2025-06-05 |
Pyott David E I |
Director |
RSU-Zuteilung |
30,000 |
$1.61 |
$48.3K |
30,000 |
| 2025-06-05 |
Crowell Gayle A |
Director |
RSU-Zuteilung |
30,000 |
$1.61 |
$48.3K |
30,000 |
| 2025-06-05 |
Huh Hoyoung |
Director |
RSU-Zuteilung |
30,000 |
$1.61 |
$48.3K |
30,000 |
| 2025-06-05 |
Mccourt Thomas A |
Director |
RSU-Zuteilung |
30,000 |
$1.61 |
$48.3K |
30,000 |
| 2025-06-05 |
Bruhn Suzanne Louise |
Director |
RSU-Zuteilung |
30,000 |
$1.61 |
$48.3K |
30,000 |
| 2025-06-05 |
Curnutte John T |
Director |
RSU-Zuteilung |
30,000 |
$1.61 |
$48.3K |
30,000 |
| 2025-06-05 |
Cline Darren S |
Director |
RSU-Zuteilung |
30,000 |
$1.61 |
$48.3K |
30,000 |
| 2025-06-05 |
Krognes Steve E. |
Director |
RSU-Zuteilung |
30,000 |
$1.61 |
$48.3K |
30,000 |
| 2025-06-05 |
Knobil Katharine |
Director |
RSU-Zuteilung |
30,000 |
$1.61 |
$48.3K |
30,000 |
| 2025-01-23 |
Lefebvre Eric |
Chief Medical Officer |
RSU-Zuteilung |
91,300 |
$11.14 |
$1.02M |
91,300 |
| 2025-01-23 |
Hull Hans |
Chief Business Officer |
RSU-Zuteilung |
80,300 |
$11.14 |
$894.54K |
80,300 |
| 2025-01-23 |
Coulie Bernard |
President and CEO |
RSU-Zuteilung |
325,000 |
$11.14 |
$3.62M |
325,000 |
| 2025-01-23 |
Cummings Keith Lamont |
Chief Financial Officer |
RSU-Zuteilung |
113,300 |
$11.14 |
$1.26M |
113,300 |
| 2025-01-23 |
Ouimette Mike |
General Counsel & Corp. Sec'y |
RSU-Zuteilung |
70,000 |
$11.14 |
$779.8K |
70,000 |
| 2025-01-23 |
Cheung Lily |
Chief Human Resource Officer |
RSU-Zuteilung |
25,875 |
- |
- |
50,425 |
| 2025-01-22 |
Ouimette Mike |
General Counsel & Corp. Sec'y |
Informierter Verkauf |
10,230 |
$10.99 |
$112.46K |
70,544 |
| 2025-01-17 |
Lefebvre Eric |
Chief Medical Officer |
Informierter Verkauf |
18,478 |
$11.20 |
$206.97K |
194,574 |
| 2025-01-17 |
Hull Hans |
Chief Business Officer |
Informierter Verkauf |
15,936 |
$11.20 |
$178.5K |
211,558 |
| 2025-01-17 |
Coulie Bernard |
President and CEO |
Informierter Verkauf |
52,419 |
$11.20 |
$587.15K |
430,517 |
| 2025-01-17 |
Cummings Keith Lamont |
Chief Financial Officer |
Informierter Verkauf |
20,148 |
$11.20 |
$225.68K |
262,608 |
| 2025-01-17 |
Ouimette Mike |
General Counsel & Corp. Sec'y |
Informierter Verkauf |
13,270 |
$11.20 |
$148.64K |
80,774 |
| 2025-01-17 |
Cheung Lily |
Chief Human Resource Officer |
Informierter Verkauf |
3,740 |
$11.20 |
$41.89K |
24,550 |
| 2024-07-10 |
Lefebvre Eric |
Chief Medical Officer |
Informierter Verkauf |
12,319 |
$11.56 |
$142.41K |
213,052 |
| 2024-07-10 |
Hull Hans |
Chief Business Officer |
Informierter Verkauf |
9,900 |
$11.56 |
$114.44K |
227,494 |
| 2024-07-10 |
Coulie Bernard |
President and CEO |
Informierter Verkauf |
38,710 |
$11.56 |
$447.49K |
482,936 |
| 2024-07-10 |
Cummings Keith Lamont |
Chief Financial Officer |
Informierter Verkauf |
10,911 |
$11.56 |
$126.13K |
282,115 |
| 2024-07-10 |
Ouimette Mike |
General Counsel & Corp. Sec'y |
Informierter Verkauf |
7,656 |
$11.56 |
$88.5K |
94,044 |
| 2024-07-09 |
Lefebvre Eric |
Chief Medical Officer |
RSU-Zuteilung |
24,063 |
- |
- |
225,371 |
| 2024-07-09 |
Hull Hans |
Chief Business Officer |
RSU-Zuteilung |
19,337 |
- |
- |
237,394 |
| 2024-07-09 |
Coulie Bernard |
President and CEO |
RSU-Zuteilung |
75,625 |
- |
- |
521,646 |
| 2024-07-09 |
Cummings Keith Lamont |
Chief Financial Officer |
RSU-Zuteilung |
21,313 |
- |
- |
293,026 |
| 2024-07-09 |
Ouimette Mike |
General Counsel & Corp. Sec'y |
RSU-Zuteilung |
14,954 |
- |
- |
101,700 |
| 2024-06-13 |
Pyott David E I |
Director |
RSU-Zuteilung |
26,764 |
$13.06 |
$349.54K |
26,764 |
| 2024-06-13 |
Crowell Gayle A |
Director |
RSU-Zuteilung |
26,764 |
$13.06 |
$349.54K |
26,764 |
| 2024-06-13 |
Huh Hoyoung |
Director |
RSU-Zuteilung |
26,764 |
$13.06 |
$349.54K |
26,764 |
| 2024-06-13 |
Mccourt Thomas A |
Director |
RSU-Zuteilung |
26,764 |
$13.06 |
$349.54K |
26,764 |
| 2024-06-13 |
Bruhn Suzanne Louise |
Director |
RSU-Zuteilung |
26,764 |
$13.06 |
$349.54K |
26,764 |
| 2024-06-13 |
Curnutte John T |
Director |
RSU-Zuteilung |
26,764 |
$13.06 |
$349.54K |
26,764 |
| 2024-06-13 |
Cline Darren S |
Director |
RSU-Zuteilung |
26,764 |
$13.06 |
$349.54K |
26,764 |
| 2024-06-13 |
Krognes Steve E. |
Director |
Unbekannt |
- |
- |
- |
- |
| 2024-06-13 |
Krognes Steve E. |
Director |
RSU-Zuteilung |
53,528 |
$13.06 |
$699.08K |
53,528 |
■ Informativ — Transaktion am offenen Markt (bedeutendste)
■ Nicht-informativ (Kauf) — Vergütung, Optionsausübung, Wandlung
■ Nicht-informativ (Verkauf) — Quellensteuer, Verkauf bei Vesting
■ Neutral — Schenkung, Treuhand, Verfall
